Jaguar Health, Inc. (NASDAQ:JAGX)

BRIEF

published on 12/15/2025 at 15:05, 1 day 21 hours ago

Jaguar Health soumet un résumé pour un essai clinique sur le crofélémer chez des patients atteints du syndrome de l'intestin court avec insuffisance intestinale.

Jaguar Health Syndrome De L'intestin Court Médicament Orphelin Insuffisance Intestinale Procès Crofelemer
BRIEF

published on 12/15/2025 at 15:05, 1 day 21 hours ago

Jaguar Health Submits Abstract for Crofelemer Trial in SBS-IF Patients

Short Bowel Syndrome Jaguar Health Orphan Drug Crofelemer Trial Intestinal Failure
PRESS RELEASE

published on 12/15/2025 at 15:00, 1 day 21 hours ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health announces submission of abstract detailing preliminary findings from clinical trial on a novel oral liquid formulation of crofelemer for SBS-IF patients, supporting the focus on reducing PS needs in intestinal failure patients

Crofelemer Jaguar Health Clinical Trial SBS-IF Intestinal Failure
BRIEF

published on 12/10/2025 at 15:05, 6 days 21 hours ago

FDA Extends Conditional Approval for Jaguar Health's Canalevia-CA1

FDA Approval Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy In Dogs
BRIEF

published on 12/10/2025 at 15:05, 6 days 21 hours ago

La FDA prolonge l'approbation conditionnelle du Canalevia-CA1 de Jaguar Health

Jaguar Health Canalevia-CA1 Approbation De La FDA Médecine Vétérinaire Chimiothérapie Chez Les Chiens
PRESS RELEASE

published on 12/10/2025 at 15:00, 6 days 21 hours ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) receives FDA renewal for Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs, with conditional approval extended until December 2026

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea FDA Renewal
BRIEF

published on 12/08/2025 at 22:20, 8 days 14 hours ago

Jaguar Health Announces Approval of Proposals at Stockholder Meeting

Crofelemer Microvillus Inclusion Disease FDA Approval Jaguar Health Stockholder Meeting
BRIEF

published on 12/08/2025 at 22:20, 8 days 14 hours ago

Jaguar Health annonce l'approbation de propositions lors de l'assemblée générale des actionnaires

Crofelemer Jaguar Health Approbation De La FDA Assemblée Générale Des Actionnaires Maladie À Inclusions Microvillositaires
PRESS RELEASE

published on 12/08/2025 at 22:15, 8 days 14 hours ago

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte to present updates on near-term catalysts at Emerging Growth Conference; Initial results show crofelemer may extend infants' lives with MVID; Jaguar completes FDA meeting on crofelemer trial for MVID treatment

Crofelemer Jaguar Health Lisa Conte Emerging Growth Conference MVID
BRIEF

published on 12/02/2025 at 15:05, 14 days 21 hours ago

Jaguar Health sollicite l'approbation de l'EMA pour Canalevia dans le traitement de la diarrhée canine

Jaguar Health Agence Européenne Des Médicaments Diarrhée Du Chien Approbation De Canalevia Traitement Non Antibiotique

Published on 12/17/2025 at 11:37, 48 minutes ago

Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing
Published on 12/17/2025 at 09:05, 3 hours 20 minutes ago

Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies
Published on 12/17/2025 at 08:00, 4 hours 25 minutes ago

Pulsar Helium Awards Security Based Compensation
Published on 12/16/2025 at 23:20, 13 hours 5 minutes ago

Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III
Published on 12/16/2025 at 23:20, 13 hours 5 minutes ago

GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

View all ACCESSWIRE

Published on 12/17/2025 at 12:04, 21 minutes ago

Edison issues report on VietNam Holding (VNH)
Published on 12/17/2025 at 12:00, 25 minutes ago

AngloGold Ashanti US$9.0m Gold Farm-in Commences
Published on 12/17/2025 at 11:57, 27 minutes ago

Templeton Emerging Markets Investment Trust (TEM)
Published on 12/17/2025 at 11:25, 59 minutes ago

Block listing Six Monthly Return
Published on 12/17/2025 at 11:12, 1 hour 13 minutes ago

EQS-Adhoc: CEOTRONICS receives third SmG call-off worth approximately € 47 million

View all EQS

Published on 12/16/2025 at 21:45, 14 hours 39 minutes ago

Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 16 hours 14 minutes ago

donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 16 hours 14 minutes ago

Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 17 hours 31 minutes ago

Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 17 hours 31 minutes ago

Nombre total d'actions et droits de vote - novembre 2025

View all LES ECHOS COMFI WIRE

News